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Abstract
Aims To investigate: (1) the willingness of patients with diabetes to participate in a screening programme; (2) the extent to
which patients with diabetes who screen positive endorse need for psychosocial care; (3) the rate of referral to psychosocial
care during screening vs. usual care.
Methods Four hundred and ninety-nine patients with diabetes were invited to complete the Center for Epidemiologic
Studies Depression and the Problem Areas in Diabetes questionnaires. Patients screening positive on either instrument were
invited for an interview. One year after screening was withdrawn, rates of referral to psychosocial care were assessed from
physician reports of patient referrals.
Results In total, 349 ⁄499 (70%) patients with diabetes completed the questionnaire. Patients who did not take up the
screening were younger, smoked more often and had higher HbA1c values. ‘No-shows’ for clinical appointments accounted
for 74% of non-participation. Of the 104 (30% of 349) patients screening positive, 45 accepted an invitation for an
interview. Finally, 36 ⁄104 (35%) would like a referral for psychological care. Seven per cent of patients were referred to
psychological care during screening compared with 1% when screening was withdrawn.
Conclusions Results raise questions as to whether screening is the most efficient way to identify patients with psychological
problems. Many patients did not take up the screening, especially those with low adherence to diabetes care in general.
Furthermore, few patients screening positive wanted to be referred. Screening should be evaluated in the context of con-
sideration of alternative ways to identify at-risk patients, including providing resources to deal with patients with already
known adjustment and adherence problems.
Diabet. Med. 30, 88–94 (2013)
Introduction
Psychological problems such as depressive symptoms and dia-
betes-related distress are common in both patients with Type 1
and Type 2 diabetes [1,2]. These problems compromise
diabetes care tasks and negatively impact health status. Yet,
patients with psychological problems do not typically self-
identify, and they often go unrecognized by care providers [3],
leading to under-treatment [4]. Therefore, international diabe-
tes guidelines [5,6] now recommend routinely screening
patients with diabetes for depressive symptoms and diabetes-
related distress. The rationale is that these problems are
common and detectable, and efficient treatments are available,
such as cognitive behavioural therapy and antidepressant
medication [7].
Guidelines recommend routine screening for psychological
problems in diabetes care on the assumption that implemen-
tation (1) increases the detection of patients with diabetes with
psychological problems and (2) leads to referral to appropriate
and effective mental health care, and ultimately to improve-
ment in patient outcomes [8]. Yet, for screening to function
efficiently, as assumed, several conditions must be met.
First, patients with diabetes must be willing to participate in
each of the two stages of screening. The first stage involves
completion of a short screening questionnaire; the second stage
entails a follow-up interview with a specialized healthcare
worker to discuss high scores and any associated need for
additional care [9]. Thus, for the goals of screening to be met,Correspondence to: Joke Fleer. E-mail: j.fleer@umcg.nl
DIABETICMedicine
DOI:10.1111/dme.12001
ª 2012 The Authors.
88 Diabetic Medicine ª 2012 Diabetes UK
patients with diabetes must be willing to complete a screening
questionnaire in which they volunteer their mood state, and
those with elevated scores must be willing to further discuss
their problems in an interview with a specialized healthcare
worker. If patients with diabetes find either component of
psychological screening unacceptable, there will be a smaller
yield of patients than anticipated.
Second, patients with diabetes who screen positive must be
willing to accept a possible referral for additional psychosocial
care. However, there are indications from studies in patients
with diabetes [10,11] and other medical conditions (e.g.
[12,13]) that only a minority of patients with elevated levels of
psychological problems will accept formal psychological
services. In these studies, many patients screening positive were
found to be already in treatment, did not feel that a particular
healthcare setting was an appropriate place for receiving help,
or did not view themselves as needing help. This suggests that a
substantial portion of patients with diabetes with heightened
distress levels do not present with unmet needs that could be
met with available and acceptable psychological treatment [14–
16]. If this is the case for patients with diabetes, then screening
might prove a costly and inefficient method to identify what
could be a relatively small group of patients with diabetes with
an addressable unmet need.
The aim of this paper is to investigate whether screening
functions as efficiently as assumed and, thus, if it should be
recommended as part of standard diabetes care. Therefore, we
investigate:
1. the willingness of patients with diabetes to participate in
screening;
2. the extent to which patients with diabetes who screen
positive for psychological problems (1) have unmet needs,
(2) have no need for help or (3) already are receiving help;
3. the extent to which introduction of screening improves
referral to psychological care relative to a comparable
period of clinical care as usual.
Patients and methods
Patients and procedure
For 9 weeks between March and June 2009, consecutive
patients with diabetes visiting the diabetes outpatient clinic of
the University Medical Center Groningen, in the Netherlands,
were approached for this study. The University Medical Center
Groningen is a tertiary referral centre with a relatively high
percentage of complex patients with Type 2 diabetes under
treatment. Exclusion criteria were: age younger than 18 years
or older than 70 years, a chart notation of serious psychiatric
problems such as schizophrenia or autism, not being able to
read Dutch, visual problems, and pregnancy.
Patients who met the inclusion criteria received a letter
2 weeks prior to their appointment, inviting them to complete
an online screening questionnaire assessing depressive symp-
toms and diabetes-related distress, as part of standard clinical
care. A web link to the questionnaire and a unique identifi-
cation code were provided. The letter also indicated that a
computer would be available at the outpatient clinic so that
patients without the Internet at home could complete the
questionnaire. For those patients who were unwilling to use
the computer, paper questionnaires were available at the
outpatient clinic, which could be completed either on the day
of their appointment with the physician or at home (a prepaid
return envelope was provided). Clinic schedules were checked
daily to see whether the patients who had an appointment had
already completed the screening questionnaire. If they had
not, a research assistant approached them in the waiting room
to once more invite them to complete the screening ques-
tionnaire.
Patients who scored above the cut-off scores on either
depressive symptoms or diabetes-related distress received a
phone call within 1 week from a psychologist to invite them
for an interview at the University Medical Center Groningen.
Patients who missed their diagnostic interview, or who were
unable to attend, were offered a new appointment. The pur-
pose of the interview was to identify the source of their
depressive symptoms or diabetes-related distress, discuss whe-
ther they had a need for additional care, and to refer them to
additional services when needed. The choice of additional
services was tailored to the specific needs of patients, and could
vary from watchful waiting to referral to a psychiatrist, or
rehabilitation.
The comparison of rates of referral during screening to after
screening was withdrawn and rates of referral to psychosocial
care without screening were assessed 1 year later, i.e. for
9 weeks between March and June 2010. During this 1-year
period, no changes to the provision of psychosocial care were
implemented. A research assistant contacted each physician
weekly and provided the list of patients who had been seen
during that week. Physicians had to indicate whether each
patient was referred to psychosocial psychiatry, psychology,
social services or rehabilitation. We used similar criteria to
select patients as in the screening study.
Patient identity was protected by unique patient identifiers.
According to Dutch law, no further Institutional Review Board
approval was required.
Measures
Data on diabetes (i.e. type of diabetes, duration of diabetes,
HbA1c values, treatment for diabetes, other chronic diseases)
and lifestyle (BMI, smoking, alcohol use) were obtained from
medical records, and demographics (i.e. age, gender) were
provided by patients.
Depressive symptoms were measured with the Center of
Epidemiologic Studies Depression (CES-D) scale [17]. The
CES-D scale is a 20-item self-report questionnaire measuring
depressive symptoms in the general population and in the
medically ill. A total sum score is used (0–60), with higher
scores indicating more depressive symptoms. A cut-off point of
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‡ 16 is generally used to define patients at risk for clinical
depression [18].
Diabetes-related distress was measured using the Problem
Areas in Diabetes (PAID) scale [19,20]. The PAID consists of
20 Likert scale items. A total sum score is used (20–100), with
higher scores indicating more diabetes-related distress. A cut-
off point of ‡ 40 is generally used to define patients at risk for
high diabetes-related distress.
Statistical analyses
Statistical analyses were performed using SPSS 16.0 (SPSS Inc.,
Chicago, IL, USA). Descriptive statistics were calculated:
means, frequencies and percentages. Chi-square tests and t-tests
compared groups (i.e. respondents vs. non-respondents; inter-
view vs. no interview) on socio-demographics, diabetes-related
variables, the CES-D and the PAID scales. A v2-test was also
used to compare referral rates during screening vs. after
cessation of screening.
Results
Willingness of patients to participate in the first stage of
screening
A total of 499 patients with diabetes met the inclusion criteria
and were invited to complete a screening questionnaire; 347
(69.5%) completed the screening questionnaire (Fig. 1).
The 152 patients with diabetes not completing the ques-
tionnaire included six with incomplete responses. Another 19
(13%) explicitly declined participation in screening when
approached by a research assistant in the waiting room.
Reasons for non-response were not directly assessed for the
other 127 patients. However, 113 of these 127 non-respon-
dents (88.9%; 74.3% of 152 non-respondents) did not show
up at the outpatient clinic for their appointment with the
physician.
The 152 patients with diabetes not completing the first stage
of screening were significantly younger, had higher HbA1c
499 patients with diabetes met 
inclusion criteria
347 screening questionnaires 
243 no elevated scores (CES-D < 16; PAID
< 40)
104 at least one elevated score 
(CES-D ≥ 16 and/or PAID ≥ 40):
70 only CES-D ≥ 16
28 CES-D ≥ 16 and PAID ≥ 40
6 only PAID ≥ 40
50 accepted invitation for interview 
54 no interview:
11 not reached
35 not interested/no time




2 already received psychiatric help
45 interviews
152 non-response (including six incomplete 
questionnaires)
36 referrals for psychosocial care 
[e.g. psychologist (n = 30), psychiatrist 
(n = 3), rehabilitation (n = 1), social work 
(n = 1), diabetes nurse (n = 1)]
FIGURE 1 Screening flow chart. CES-D, Center of Epidemiologic Studies Depression; PAID, Problem Areas in Diabetes.
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values and were more likely to smoke than the 347 patients
with diabetes who responded. The groups did not differ on
other demographic, diabetes or lifestyle variables (Table 1).
Willingness of patients to participate in second stage of
screening
Of the 347 patients with diabetes who completed the screening
questionnaire, 104 (30.0%) scored above the cut-off of the
CES-D and ⁄or PAID scales. Of these 104 patients with elevated
scores, 70 (67.3%) were identified as at risk for a clinical
depression (CES-D ‡ 16), 28 (26.9%) were identified as at risk
for both a clinical depression and high diabetes-related distress
(CES-D ‡ 16 and PAID ‡ 40) and six (5.8%) were identified as
at risk for high diabetes-related distress (PAID ‡ 40) (Fig. 1).
All 104 patients with elevated scores were telephoned to
invite them for a psychological interview. Eleven (10.6%) could
not be reached, despite several attempted telephone calls and a
letter. Thirty-five (33.7%) were not interested or had no time,
and eight (7.7%) already received help. Five patients accepted
the invitation for the interview, but did not show up for their
appointment; four patients cancelled because of physical
problems that required attendance first, and one patient forgot
the appointment and was not interested in a new appointment.
In total, 45 patients (43.3%) with elevated scores accepted an
interview.
Patients who received an interview did not differ from those
who did not on the CES-D or the PAID scales, or on demo-
graphic, disease or lifestyle variables (all P > 0.05, data not
reported).
Need for psychological care
Of the 104 patients with diabetes with heightened depressive
symptoms or diabetes-related distress, 36 (34.6%) indicated an
unmet need for which they would like a referral for additional
psychosocial care. Fifty-eight patients (55.7%) were either not
interested in additional care (n = 42), could not be reached
after several attempts (n = 11) or dropped out before interview
(n = 5), and 10 (9.6%) had already received help (Fig. 1).
Comparison with rates of referrals after cessation of formal
screening
Of the 528 patients meeting the inclusion criteria in the com-
parison period 1 year after cessation of formal screening, six
(1.1% of 528 patients) were referred for additional psychoso-
cial services (i.e. three to a psychiatrist, two to a psychologist
and one to rehabilitation) by their physician. This was signifi-
cantly lower than the percentage of patients referred to psy-
chosocial care during screening in 2009 (n = 36 of 499, 7.2%;
v2 = 24.16, P < 0.0001).




(n = 152*) Significance
Age (mean  sd) 50.4  13.2 46.3  13.3 (t = )3.16; P = 0.002)
Gender, n (%)
Male 181 (52.2%) 79 (52.0%) (v2 = 0.001;P = 0.97)
Female 167 (47.8%) 73 (48.0%)
Type of diabetes, n (%)
Type 1 166 (48.0%) 69 (45.4%) (v2 = 0.28; P = .60)
Type 2 180 (52.0%) 83 (54.6%)
Duration of diabetes (mean  sd) 16.9  12.3 15.8  11.7 (t = )0.92; P = 0.36
HbA1c mmol ⁄mol
(mean  sd)
62  8 66  6 (t = 2.70; P = 0.007)
% (mean  sd) 7.8  1.4 (8.2  1.6)
Treatment, n (%)
Tablets 31 (9.0%) 13 (8.6%) (v2 =0.19; P = 0.91)
Tablets + insulin 80 (23.3%) 38 (25.0%)
Insulin 233 (67.7%) 101 (66.4%)
‡ 1 other chronic disease, n (%)
No 183 (52.7%) 82 (53.9%) (v2 = 0.06; P = 0.80)
Yes 164 (46.3%) 60 (46.1%)
BMI (mean  sd) 29.6  6.6 29.7  7.3 (t = 0.08; P = 0.94)
Smoking
No 270 (79.6%) 101 (67.3%) (v2 = 8.51; P = 0.004)
Yes 69 (20.4%) 49 (32.7%)
Alcohol drinking
Not at all 134 (39.6%) 62 (41.6%) (v2 = 0.23; P = 0.89)
Sometimes 159 (47.0%) 69 (46.3%)
Daily 45 (13.3%) 18 (12.1%)
*Number is slightly variable because of missing data.
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Discussion
International guidelines recommend routine screening as a
method to identify patients with diabetes in need of psycho-
logical care [5,6]. However, there is no randomized trial yet
demonstrating that routine screening improves patient out-
comes over what is obtained in routine care with patients
having similar access to discussions with professionals and
services [21]. Our results raise questions as to whether screen-
ing is an efficient means to identify these patients. Many
patients were missed by screening, despite being offered
multiple ways to obtain it, and only a relatively small propor-
tion of patients who screened positive desired a referral. In part,
because of this low percentage of patients with a meetable
unmet need, referral rates only increased from 1 to 7% when
screening was implemented, compared with usual care.
The 30% of patients missed by screening had higher HbA1c
values, were younger and were more likely to smoke.
Furthermore, three quarters of these patients did not show up
at the outpatient clinic for their appointment with the physi-
cian, perhaps indicating low adherence to diabetes care in
general, and not specifically low enthusiasm for screening or
psychological services. Low treatment adherence, as well as
high HbA1c, young age and smoking have been associated with
depression [22,22–24]. Thus, it seems that a group with specific
characteristics indicative of a need for greater outreach to them,
is being missed with screening.
Taken together, our results suggest that screening may not be
as efficient as anticipated, nor cost-effective. Although this
study did not incorporate a formal cost analysis, it shows that,
to complete a referral, diabetes outpatient clinics would have to
meet considerable costs. In this study, to refer 36 patients, 499
questionnaires had to be sent out; research assistants had to be
present at the outpatient clinic on a daily basis to approach the
non-responders; over 104 calls had to be completed to those
with elevated scores, with many patients requiring multiple
calls to reach them; and 45 psychological interviews had to be
conducted by trained psychologists, some with multiple
rescheduling after ‘no-shows’ or cancellation. Diabetes clinics
contemplating implementation of a screening programme
should thus compare the introduction of routine screening to
alternative uses of resources.
One alternative approach to using a screening questionnaire
in the first stage of routine screening for depression and
diabetes-related distress would be to ask patients during
consultation about their well-being [6], and whether they have
an unmet need for psychological care or for support that they
wish to have addressed [25,26]. Yet, it has not been established
whether patients perceive an appointment with their physician
as an appropriate occasion for seeking or receiving a referral for
psychological treatment.
Another alternative would be to identify patients who
consistently miss appointments or whose medical records indi-
cate problems with adherence and offer them additional diabetes
education. There is some indication that a patient-tailored
approach to diabetes education, which does not specifically tar-
get depressive symptoms, may nevertheless cause a significant
improvement in glycaemic control and reduction in depression
[27,28]. Reductions in depression after diabetes education have
been found to be comparable with what is obtained with cog-
nitive behaviour therapy [29], fluoxetine [30] and nortryptyline
[31]. It might thus be sensible to monitor emotional well-being in
more vulnerable patients, such as those with a history of
depression or adjustment problems. A history of depression is an
important risk factor for incident depression [32]. Bot et al. [33]
have shown that the 2-year incidence of major depression was
42% in patients with diabetes with sub-threshold depression.
A recent review also concluded that, despite the promulga-
tion of recommendations for screening patients with diabetes
for depression, there is a lack of evidence that screening
improves outcomes [21]. The review endorsed collaborative
care for depression in patients with diabetes. Over 40 studies
have now demonstrated that collaborative care involving a
dedicated care manager improves outcomes for depression in
primary care [34], and this work has been extended to patients
with diabetes, demonstrating improvement in both depression
and diabetes-specific outcomes [35]. However, despite its
demonstrated efficacy, it should be noted that collaborative care
requires considerable resources and there are very few instances
of sustained implementation outside of research projects and
especially well-organized and resourced clinical settings.
Perhaps there are lessons to be learned for diabetes care from
guidelines for screening for depression in primary care. The
United States Preventive Services Task Force (USPSTF) only
recommends screening of patients for depression where there is
an integrated depression management system, but not where
such resources are not available.
Limitations
Results of this study should be interpreted in the context of its
limitations. First, one of the endpoints of this study was referral
to mental health services, based on a positive score on a
depression questionnaire, which is not equivalent to a diag-
nosable depression for which empirically based treatment
guidelines have been firmly established. While the CES-D scale
is widely used for screening and is recommended by the
International Diabetes Federation [6] as instrument of choice
for screening of depression, it has a positive predictive value
(i.e. the proportion of correct positive screening outcomes) of
only approximately 40% for major depression [36]. Although
there are alternative screening instruments available, such as
the shorter Patient Health Questionnaire (PHQ-9), there are
currently no indications that one scale performs better as a
depression screener than another [37]. Second, we have no
information as to whether patients’ referrals were completed,
or that they remained in mental health treatment long enough
to obtain an adequate exposure to treatment or whether the
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treatment was evidence based. Thus, our simple registry of
whether a referral was made probably overestimates whether
referral actually led to patient improvement.
Third, our two-stepped screening procedure using validated
and reliable screening instruments is consistent with recom-
mendations from literature. However, we put considerable effort
into approaching patients and granted greater flexibility in
scheduling and rescheduling follow-up interviews than might be
sustained in routine care. This might have led to an overestima-
tion of the number of patients willing to complete a screening
questionnaire, or to participate in a psychological interview.
Finally, although low, the referral rates we found in usual
clinical care 1 year later may nonetheless have been increased
by the fact that screening previously had been in place. This
may have sensitized physicians to psychological problems and,
thus, to an increase in referral rates in usual clinical care.
Conclusions
Our results raise questions as to whether screening is the most
efficient way to identify patients with diabetes with depressive
symptoms and diabetes-related problems. Many patients were
missed despite being offered multiple means for screening,
especially those with low adherence to diabetes care in general.
Furthermore, few patients screening positive desired a referral.
Screening should be evaluated in the context of consideration
of alternative ways to identify at-risk patients, including pro-
viding resources to deal with patients with already known
adjustment and adherence problems, and integration of
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